Evidence map›Paper›PMID 42129069›Full record

ReviewAdvances in experimental medicine and biology2026

Proteomic Technology.

Timothy Daniel Veenstra

Abstract readHistorical ArticleReview
PubMed Publisher
In one paragraph

Review in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Timothy Daniel VeenstraCollege of Medicine, Lake Erie College of Osteopathic Medicine, Bradenton, FL, USA. tveenstra@lecom.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The proteome is defined as the total protein complement of a genome-whether that genome is associated with an individual cell, tissue, or organism (Wasinger et al., Electrophoresis 16:1090-1094, 1995). Proteomics refers to the application of technologies to characterize the proteome. The term "proteome" was coined by researchers at the University of Sydney, Australia, in a paper published in 1995 (Wasinger et al., Electrophoresis 16:1090-1094, 1995). But did proteomics really begin in 1995 or were researchers doing proteomic research long before? As a PhD student, I would tell people that my field of expertise was protein science, as I was involved in determining the three-dimensional structures of proteins using nuclear magnetic resonance (NMR) spectroscopy. As my career evolved to using mass spectrometry (MS) to analyze complex mixtures of proteins, my field of expertise was proteomics. While still studying proteins, what had changed was the number of proteins I was analyzing per experiment. In a nutshell, proteomics is simply the large-scale study of proteins. While protein scientists have been studying proteins for almost 200 years (Mulder, Bulletin des Sciences Physiques et Naturelles en Néerlande 104, 1838), proteomics has increased the throughput and the ability to characterize proteins in the context of other proteins within their environment. While well-known for its high-throughput ability to identify and quantitate proteins, proteomics encompasses several different facets of protein characterization including such things as structure, function, protein-protein interactions, posttranslational modifications, and protein quantitation. Data acquired under any of these broad categories can be applied to greater understand something part of the cell system.

Indexed as

ProteomeProteomicsAnimalsHistory, 20th CenturyHistory, 21st CenturyHumansMass SpectrometryProteomeDiscovery-drivendiscovery-drivenLiquid chromatographyliquid chromatographyMass spectrometrymass spectrometryProtein arrayProtein complexProteomicsproteomicsPull-down assayYeast two-hybridyeast two-hybrid assay

Identifiers

PMID42129069

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.